DEA Advances Psilocybin Rescheduling Petition to HHS for Scientific Review

Psylutions, Colorado's first licensed regulated cultivator and manufacturer of psilocybin, welcomes the U.S. Drug Enforcement Administration's decision to forward a petition to reschedule psilocybin to the U.S. Department of Health and Human Services for scientific review. The move marks a significant regulatory milestone in the decades-long effort to integrate psychedelics into mainstream medicine. Rhonda DeSantis, founder of Psylutions, stated that this crucial step reflects a long-overdue alignment between policy and science and brings healing one step closer to those who need it most.

If psilocybin is moved from Schedule I to Schedule II of the Controlled Substances Act, patients in palliative care and Veterans suffering from PTSD would be among the first to benefit through expanded pathways like Right to Try. Rescheduling would also accelerate research opportunities and expand access for clinicians and licensed healing centers. Henry Baskerville, General Counsel and Partner at Psylutions, described this development as signaling a regulatory awakening where agencies begin engaging with medical evidence over stigma, creating a watershed moment for psychedelics.

Psylutions has invested heavily in infrastructure to meet the highest standards of safety and precision, including strain optimization, lab-verified dosing, and triple HEPA filtration systems to mitigate contamination risk. The company already partners with over 50% of healing centers operating across Colorado to provide regulated psilocybin solutions for chronic pain, trauma relief, end-of-life care, and broader mental wellness. DeSantis emphasized that as soon as psilocybin is rescheduled from Schedule I, patients facing terminal illness and Veterans at risk of suicide will finally have safe, legal access through Right to Try, with Psylutions committed to ensuring that access is built on medicine that is effective, rigorously verified, and responsibly produced. Learn more at https://ThePsylutions.com.